GlaxoSmithKline to buy California biotech firm Sierra Oncology for $1.9B
April 13, 2022 at 10:28 AM EDT
The San Mateo-based biotech company is focused on developing treatments for rare types of cancer.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |